Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharma
STAT+

Week of Feb. 20: What to watch for in biopharma

  • Rebecca Robbins

By Rebecca Robbins Feb. 20, 2017

Reprints
The Week Ahead
Alex Hogan/STAT

Here’s what we’re looking out for this week in the worlds of pharma and biotech:

Dr. Patrick Soon-Shiong unveils his next big thing

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
52 weeks, 52 faces: Obituaries narrate lives lost to…
52 weeks, 52 faces: Obituaries narrate lives lost to the opioid epidemic
Bernie Sanders’ accidentally great drug pricing idea
Bernie Sanders’ accidentally great drug pricing idea
Pharmalittle: FDA proposes more rigorous cancer drug trials for…
Pharmalittle: FDA proposes more rigorous cancer drug trials for accelerated approval; insurers not covering obesity meds…
Under protest, FDA to convene advisory panel to review…
Under protest, FDA to convene advisory panel to review controversial cell therapy for ALS

Recommended Stories